Skip to main content
. 2025 Jun 6;312(3):841–848. doi: 10.1007/s00404-025-08080-w

Table 2.

Operative and postoperative outcomes

Fertility-sparing (N = 4) Primary staging (N = 12)
Ovarian operation
Bilateral oophorectomy 0 12 (100)
Unilateral oophorectomy 2 (50.0) 0
Unilateral cystectomy 2 (50.0) 0
Accompanying procedure
 Hysterectomy 0 12 (100)
 Omentectomy 1 (25.0) 4 (33.3)
 PLND 0 3 (25.0)
Operative time, min 105 [91, 108] 135 [114, 221]
EBL, mL 75 [50, 125] 100 [100, 200]
Intraoperative complications 0 1 (8.3)
VAS pain score
 4 h post-operatively 2 [1.5, 2.25] 0 [0, 0.75]
 8 h post-operatively 0 [0, 0] 0 [0, 0.5]
 12 h post-operatively 0 [0, 1] 0 [0, 0]
 24 h post-operatively 0 [0, 0.25] 0 [0, 0]
Length of stay, days 2 [2] 2.5 [2, 3]
Tumor type
 Ovarian only 4 (100) 7 (58.3)
 Ovarian + endometrial 0 3 (25.0)
 Ovarian + fallopian tube 0 2 (16.7)
Peritoneal washings positive 0 2 (16.7)
Omental biopsy positive 0 1 (8.3)
Postoperative chemotherapy
 Indicated and received 1 (33.3) 4 (33.3)
 Indicated but declined by patient 0 4 (33.3)
 Not indicated 2 (66.7) 4 (33.3)
Follow-up time, months 11.7 [7.1, 17.7] 27.6 [7.8, 31.4]

Expressed as median [interquartile range] or n (%)

EBL estimated blood loss, PLND pelvic lymph node dissection, VAS Visual Analog Scale